Unity Historical Income Statement

UBX Stock

USD 1.24 0.03 2.48%

Historical analysis of Unity Biotechnology income statement accounts such as Interest Income of 3.3 M, Depreciation And Amortization of 1.5 M, Interest Expense of 1.9 M or Selling General Administrative of 18.9 M can show how well Unity Biotechnology performed in making a profits. Evaluating Unity Biotechnology income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Unity Biotechnology's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Unity Biotechnology latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Unity Biotechnology is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.

About Unity Income Statement Analysis

Unity Biotechnology Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Unity Biotechnology shareholders. The income statement also shows Unity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Unity Biotechnology Income Statement Chart

At this time, Unity Biotechnology's Interest Income is fairly stable compared to the past year. Depreciation And Amortization is likely to rise to about 1.5 M in 2024, despite the fact that Net Interest Income is likely to grow to (273.6 K).

Selling General Administrative Other Operating Expenses Cost Of Revenue

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Unity Biotechnology. It is also known as Unity Biotechnology overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Unity Biotechnology income statement and represents the costs associated with goods and services Unity Biotechnology provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Unity Biotechnology's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Unity Biotechnology current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.At this time, Unity Biotechnology's Interest Income is fairly stable compared to the past year. Depreciation And Amortization is likely to rise to about 1.5 M in 2024, despite the fact that Net Interest Income is likely to grow to (273.6 K).

	2021	2022	2023	2024 (projected)
Total Operating Expenses	61.4M	57.8M	44.7M	67.0M
Cost Of Revenue	2.9M	2.2M	19.7M	14.1M

Total Operating Expenses Cost Of Revenue

Unity Biotechnology income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Selling General Administrative	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Reconciled Depreciation	Non Operating Income Net Other	Non Recurring	Selling And Marketing Expenses
Net Interest Income		0.51	-0.14	0.4	-0.4	0.69	-0.71	-0.66	-0.72	0.76	-0.74	0.53	0.69	-0.63	0.42	-0.62	-0.58	0.35	0.58	-0.12	-0.12
Interest Income	0.51		-0.51	-0.12	-0.65	0.04	-0.01	-0.01	0.02	0.02	-0.01	0.33	0.04	0.09	0.07	0.1	0.23	-0.2	0.32	-0.46	-0.46
Depreciation And Amortization	-0.14	-0.51		0.5	-0.08	0.33	-0.32	-0.37	-0.3	0.23	-0.26	0.16	0.33	-0.34	0.17	-0.4	-0.23	0.45	-0.61	-0.13	-0.13
Selling General Administrative	0.4	-0.12	0.5		0.11	0.9	-0.87	-0.89	-0.85	0.78	-0.84	-0.17	0.9	-0.82	0.79	-0.82	-0.83	0.88	0.32	-0.31	-0.31
Gross Profit	-0.4	-0.65	-0.08	0.11		-0.01	0.04	0.05	0.0	-0.03	-0.01	-0.75	-0.01	0.01	0.22	0.04	-0.3	0.14	0.22	0.18	0.18
Other Operating Expenses	0.69	0.04	0.33	0.9	-0.01		-0.98	-0.98	-0.98	0.96	-0.97	0.02	1.0	-0.94	0.71	-0.93	-0.89	0.89	0.51	-0.21	-0.21
Operating Income	-0.71	-0.01	-0.32	-0.87	0.04	-0.98		0.99	0.99	-0.98	0.99	-0.06	-0.98	0.98	-0.66	0.98	0.89	-0.86	-0.52	0.04	0.04
Net Income From Continuing Ops	-0.66	-0.01	-0.37	-0.89	0.05	-0.98	0.99		0.98	-0.96	0.98	-0.02	-0.98	0.98	-0.65	0.98	0.85	-0.89	-0.48	0.09	0.09
Ebit	-0.72	0.02	-0.3	-0.85	0.0	-0.98	0.99	0.98		-0.98	1.0	-0.07	-0.98	0.97	-0.62	0.96	0.9	-0.86	-0.54	0.04	0.04
Research Development	0.76	0.02	0.23	0.78	-0.03	0.96	-0.98	-0.96	-0.98		-0.98	0.09	0.96	-0.97	0.59	-0.96	-0.89	0.84	0.59	0.02	0.02
Ebitda	-0.74	-0.01	-0.26	-0.84	-0.01	-0.97	0.99	0.98	1.0	-0.98		-0.06	-0.97	0.96	-0.62	0.96	0.9	-0.85	-0.58	0.04	0.04
Cost Of Revenue	0.53	0.33	0.16	-0.17	-0.75	0.02	-0.06	-0.02	-0.07	0.09	-0.06		0.02	-0.01	-0.18	-0.05	0.08	-0.27	-0.27	0.0	0.0
Total Operating Expenses	0.69	0.04	0.33	0.9	-0.01	1.0	-0.98	-0.98	-0.98	0.96	-0.97	0.02		-0.94	0.71	-0.93	-0.89	0.89	0.51	-0.21	-0.21
Income Before Tax	-0.63	0.09	-0.34	-0.82	0.01	-0.94	0.98	0.98	0.97	-0.97	0.96	-0.01	-0.94		-0.56	1.0	0.86	-0.88	-0.5	-0.11	-0.11
Total Other Income Expense Net	0.42	0.07	0.17	0.79	0.22	0.71	-0.66	-0.65	-0.62	0.59	-0.62	-0.18	0.71	-0.56		-0.54	-0.77	0.53	0.4	-0.4	-0.4
Net Income	-0.62	0.1	-0.4	-0.82	0.04	-0.93	0.98	0.98	0.96	-0.96	0.96	-0.05	-0.93	1.0	-0.54		0.84	-0.88	-0.44	-0.1	-0.1
Income Tax Expense	-0.58	0.23	-0.23	-0.83	-0.3	-0.89	0.89	0.85	0.9	-0.89	0.9	0.08	-0.89	0.86	-0.77	0.84		-0.75	-0.57	-0.05	-0.05
Reconciled Depreciation	0.35	-0.2	0.45	0.88	0.14	0.89	-0.86	-0.89	-0.86	0.84	-0.85	-0.27	0.89	-0.88	0.53	-0.88	-0.75		0.37	-0.15	-0.15
Non Operating Income Net Other	0.58	0.32	-0.61	0.32	0.22	0.51	-0.52	-0.48	-0.54	0.59	-0.58	-0.27	0.51	-0.5	0.4	-0.44	-0.57	0.37		0.09	0.09
Non Recurring	-0.12	-0.46	-0.13	-0.31	0.18	-0.21	0.04	0.09	0.04	0.02	0.04	0.0	-0.21	-0.11	-0.4	-0.1	-0.05	-0.15	0.09		1.0
Selling And Marketing Expenses	-0.12	-0.46	-0.13	-0.31	0.18	-0.21	0.04	0.09	0.04	0.02	0.04	0.0	-0.21	-0.11	-0.4	-0.1	-0.05	-0.15	0.09	1.0

Click cells to compare fundamentals

Unity Biotechnology Account Relationship Matchups

Unity Biotechnology income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Net Interest Income	3.3M	(96K)	(3.1M)	(2.3M)	(288K)	(273.6K)
Interest Income	3.3M	1.2M	100K	1.2M	3.2M	3.3M
Depreciation And Amortization	2.2M	(2.7M)	3.4M	2.9M	1.2M	1.5M
Selling General Administrative	20.0M	24.0M	23.1M	20.9M	18.8M	18.9M
Gross Profit	(2.7M)	(3.4M)	1.9M	(1.9M)	(19.7M)	(20.7M)
Other Operating Expenses	91.0M	91.3M	61.4M	57.8M	44.7M	67.0M
Operating Income	(89.7M)	(93.9M)	(56.7M)	(57.6M)	(44.7M)	(46.9M)
Net Income From Continuing Ops	(82.2M)	(93.8M)	(60.7M)	(60.1M)	(52.5M)	(55.2M)
Ebit	(89.7M)	(92.6M)	(57.5M)	(40.9M)	(38.5M)	(40.4M)
Research Development	71.0M	67.3M	38.4M	36.9M	20.1M	34.4M
Ebitda	(92.4M)	(89.1M)	(54.7M)	(38.7M)	(37.3M)	(39.1M)
Cost Of Revenue	2.7M	3.4M	2.9M	2.2M	19.7M	14.1M
Total Operating Expenses	91.0M	91.3M	61.4M	57.8M	44.7M	67.0M
Income Before Tax	(82.2M)	(93.8M)	(60.7M)	(59.9M)	(39.9M)	(41.9M)
Total Other Income Expense Net	7.5M	86K	(4.1M)	13.1M	4.8M	5.0M
Net Income Applicable To Common Shares	(82.2M)	(93.8M)	(60.7M)	(59.9M)	(53.9M)	(56.6M)
Net Income	(74.9M)	(91.9M)	(60.0M)	(57.7M)	(39.9M)	(41.9M)
Income Tax Expense	(7.3M)	(2.0M)	(686K)	(2.2M)	6.2M	6.5M
Reconciled Depreciation	2.2M	2.7M	3.4M	2.9M	1.4M	2.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Unity Stock Analysis

When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Unity Historical Income Statement

About Unity Income Statement Analysis

Unity Biotechnology Income Statement Chart

Other Operating Expenses

Cost Of Revenue

Unity Biotechnology income statement Correlations

Unity Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Unity Biotechnology income statement Accounts

Also Currently Popular

Additional Tools for Unity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Selling And Marketing Expenses	+ 1.0	Non Recurring
Net Income From Continuing Ops	+ 0.99	Operating Income
Ebit	+ 0.99	Operating Income

Ebitda	- 0.98	Research Development
Total Operating Expenses	- 0.98	Ebit
Research Development	- 0.98	Ebit
Total Operating Expenses	- 0.98	Net Income From Continuing Ops
Total Operating Expenses	- 0.98	Operating Income
Research Development	- 0.98	Operating Income